| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and COO | Chief Operating Officer | Chief Operating Officer
1 company
Radovich Peter serves as a President and COO at MIRM. Across recent SEC filings that breaks down to 0 buys and 16 sells. Those positions are worth an estimated $1.1M at current prices.
Historically, Radovich Peter's trades have earned a below-average insider score of 36/100 across 13 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -71.3%.
The biggest single holding is MIRM (~$1.1M) as President and COO. The recent filings there lean toward selling, a net 66,871 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | MIRM Mirum Pharmaceuticals, Inc. | President and COO | Sell | 1,790 | $26.19 | $46,883.14 | -4.9% | -3.5% | +84.3% | |
| Jan 8, 2024 | MIRM Mirum Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 1,408 | $28.03 | $39,472.58 | -3.7% | -9.1% | +47.5% | |
| Jul 3, 2023 | MIRM Mirum Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 1,425 | $25.65 | $36,546.41 | -3.6% | +14.2% | +31.3% | |
| Jan 9, 2023 | MIRM Mirum Pharmaceuticals, Inc. | President and COO | Sell | 1,379 | $20.62 | $28,438.15 | -4.0% | +24.7% | +39.4% | |
| Oct 1, 2021 | MIRM Mirum Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 1,364 | $19.26 | $26,264.50 | -10.8% | -18.8% | +8.6% |